drugset / Trial / NCT00955396
Study to Investigate the Effect of GSK1014802 on Ambulatory Blood Pressure
RandomizedCrossoverDouble-blindOther
Summary
In this study the investigators will determine whether there is any effect of GSK1014802 on ambulatory blood pressure. This will be a randomized, double-blind, placebo-controlled, repeat dose, 2 period cross-over study conducted in healthy male and female subjects. Approximately 60 subjects will be randomised to receive GSK1014802 400 mg bid and placebo for 36 days with at least 1 week between treatment sessions. A follow-up will occur 7-14 days after the last dose.
Timeline
- Start
- 2009-07-31
- Primary completion
- 2009-12-31
- Completion
- 2009-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vixotrigine | Small molecule | 400 mg | — |
Indications
No indication recorded.